News
Research Innovation
Plasma donation
Product Center
Career Development
China Grand Enterprises, Inc. was established in 1993, with main business covering six major sectors: pharmaceuticals and healthcare, ecological agriculture, grease, trade, real estate investment, and financial services. As one of the core group companies within the China Grand Enterprises Pharmaceuticals & Healthcare, Grand Life Sciences Group has established six major business sectors: blood products, APIs, polymers, chemical drugs, vaccines, and probiotics. It has ten member enterprises, including production bases in Chengdu, Shenyang, Penglai, Wuhan, Henan, Nanjing, Hangzhou, and Chongqing.
Grand Shuyang Life Sciences (Chengdu) Co., Ltd.(hereinafter referred to as “Yuanda Shuyang”) is a wholly-owned subsidiary of Grand Life Sciences Group Limited, a member of China Grand Enterprises.It originated from the Plasma Institute of the Logistics Department of the Chengdu Military Command founded in 1969. Chengdu Shuyang Pharmaceutical Factory was established in 1985 and was one of the first batch of blood product manufacturers designated by the Ministry of Health In 1998, it was transferred from the Logistics Department of the Chengdu Military Command to the Chengdu Municipal People's Government. In 2001, it was fully acquired by China Grand Enterprises. Yuanda Shuyang is based in China while maintaining a global perspective, continuously deepen on technological innovation and upgrades in the field of blood products. It boasts a modern production plant that meets Chinese GMP, benchmarks EU GMP , and is highly integrated with automation and informatization. It is capable of producing a complete range of blood products, and ranks among the top companies in China in terms of single production capacity. Yuanda Shuyang takes "focusing on blood products and synergizing biomedicine" as its development strategy and adheres to the development path of "high quality standards, full product coverage, and market internationalization" .It has entered Top 20 of Chinese biopharmaceutical companies and is striving to become an international high-quality service provider for the whole product chain of blood products.
Period of Military Support (1969-1984)
Diversification & Exploration Period (1985-2001)
Period of Enlargement and Development (2001-2020)
Period of Leaping Forward (2021-present)
Loyalty
Individual interests are organically integrated into the whole
Simplicity
Adhering to a practical and rigorous attitude and work style
Diligence
Only through diligence that surpasses our rivals can we gain an advantage
Innovation
Innovation is our only constant rule of survival
Adhering to integrity
Loyal to the enterprise, sincere in our profession, devout in our career
Embodying excellence
Complying with standards, prioritizing the brand, leading the industry
Striving for innovation
Innovation of thought, technology, and management
Nurturing harmony
A harmonious mindset for a harmonious team and a harmonious society
An international high-quality service provider covering the full product chain of blood products
MoreIn the process of becoming an “international high-quality service provider covering the full product chain of blood products”
we are committed 100% to product quality, representing our“solemn commitment to life”
From the source of plasma to the production processes control,
from product end use to customer service,
we are benchmarked to international standards in every critical process,
constantly pursuing perfection